Literature DB >> 26341656

Combined liver and kidney transplantation and kidney after liver transplantation in children: Indication, postoperative outcome, and long-term results.

Rainer Büscher1, Anja K Büscher1, Metin Cetiner1, Jürgen W Treckmann2, Andreas Paul2, Udo Vester1, Peter F Hoyer1.   

Abstract

CLKT and sequential KALT are decided on a case-by-case basis in children for special indications such as ARPKD or PH1. We report on 21 children who underwent CLKT or KALT at our hospital between 1998 and 2013. Eleven children were diagnosed with PH1 and six with ARPKD. Other diagnosis were Joubert syndrome (n = 1), nephronophthisis (n = 1), CF (n = 1), and hepatocellular carcinoma (n = 1). Children (12 males, nine females) were aged 7.8 ± 6.2 yr (range, 10 months to 18 yr) at time of transplantation. Average wait time was 1.9 ± 0.9 yr (range, four months to 2.3 yr). Fifteen patients received dialysis prior to transplantation. In PH1 patients, four children received CLKT, five received KALT, and two infants have received only an LTx, whereas all six patients with ARPKD received CLKT. In patients with other indications, CLKT was performed in three cases and KALT in one girl. Cumulative 10-yr survival of all 21 patients was 78.4%. At the time of transfer into adult care, 13 patients retained stable liver and kidney function. Regardless the underlying diagnosis, CLKT and KALT can be performed in children with good surgical outcomes and long-term survival.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autosomal recessive polycystic kidney disease; children; combined liver and kidney transplantation; kidney after liver transplantation; primary hyperoxaluria type 1

Mesh:

Year:  2015        PMID: 26341656     DOI: 10.1111/petr.12595

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  8 in total

Review 1.  Fibrocystic liver disease: novel concepts and translational perspectives.

Authors:  Alberto Lasagni; Massimiliano Cadamuro; Giovanni Morana; Luca Fabris; Mario Strazzabosco
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

2.  Pediatric combined liver-kidney transplantation: a single-center experience of 18 cases.

Authors:  Rémi Duclaux-Loras; Justine Bacchetta; Julien Berthiller; Christine Rivet; Delphine Demède; Etienne Javouhey; Rémi Dubois; Frédérique Dijoud; Alain Lachaux; Lionel Badet; Olivier Boillot; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2016-04-08       Impact factor: 3.714

3.  Outcome and natural course of renal dysfunction in liver transplant recipients with severely impaired kidney function prior to transplantation.

Authors:  T Horvatits; S Pischke; V M Proske; L Fischer; S Scheidat; F Thaiss; V Fuhrmann; A W Lohse; B Nashan; M Sterneck
Journal:  United European Gastroenterol J       Date:  2017-04-21       Impact factor: 4.623

Review 4.  Combined and sequential liver-kidney transplantation in children.

Authors:  Ryszard Grenda; Piotr Kaliciński
Journal:  Pediatr Nephrol       Date:  2018-01-10       Impact factor: 3.714

5.  Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry.

Authors:  Elisabeth L Metry; Sander F Garrelfs; Hessel Peters-Sengers; Sally-Anne Hulton; Cecile Acquaviva; Justine Bacchetta; Bodo B Beck; Laure Collard; Georges Deschênes; Casper Franssen; Markus J Kemper; Graham W Lipkin; Giorgia Mandrile; Nilufar Mohebbi; Shabbir H Moochhala; Michiel J S Oosterveld; Larisa Prikhodina; Bernd Hoppe; Pierre Cochat; Jaap W Groothoff
Journal:  Kidney Int Rep       Date:  2021-11-26

6.  Transplantation outcomes in patients with primary hyperoxaluria: a systematic review.

Authors:  Elisabeth L Metry; Liza M M van Dijk; Hessel Peters-Sengers; Michiel J S Oosterveld; Jaap W Groothoff; Rutger J Ploeg; Vianda S Stel; Sander F Garrelfs
Journal:  Pediatr Nephrol       Date:  2021-04-08       Impact factor: 3.714

7.  Deceased vs living donor grafts for pediatric simultaneous liver-kidney transplantation: A single-center experience.

Authors:  Sergey Gautier; Artem Monakhov; Olga Tsiroulnikova; Mikhail Voskanov; Igor Miloserdov; Timur Dzhanbekov; Sergey Meshcheryakov; Robert Latypov; Elena Chekletsova; Olga Malomuzh; Khizri Khizroev; Deniz Dzhiner; Irina Pashkova
Journal:  J Clin Lab Anal       Date:  2020-01-22       Impact factor: 2.352

8.  Systematic review on outcomes used in clinical research on autosomal recessive polycystic kidney disease-are patient-centered outcomes our blind spot?

Authors:  Charlotte Gimpel; Max Christoph Liebau; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2021-08-12       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.